Defective Control of Latent Epstein-Barr Virus Infection in Systemic Lupus Erythematosus

Journal of Immunology

Volumn 172, Issue 2, 2004, Pages 1287-1294

  Kang, Insoo ^a   Quan, Timothy ^a   Nolasco, Helena ^a   Park, Sung Hwan ^a,c   Hong, Myung Sun ^a   Crouch, Jill ^a   Pamer, Eric G ^b   Howe, John Greg ^a   Craft, Joe ^a,d  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^c The Catholic University of Korea   (South Korea)

^d Section of Rheumatology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD69 ANTIGEN; CD8 ANTIGEN; HLA A2 ANTIGEN;

ADULT; ARTICLE; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE PREDISPOSITION; EPSTEIN BARR VIRUS; FEMALE; HUMAN; IMMUNE RESPONSE; INTERFERON PRODUCTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SYSTEMIC LUPUS ERYTHEMATOSUS; VIRUS INFECTION; VIRUS LOAD;

EID: 1642495711     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.172.2.1287     Document Type: Article

References (58)

1. James, J. A., K. M. Kaufman, A. D. Farris, E. Taylor-Albert, T. J. Lehman, and J. B. Harley. 1997. An increased prevalence of Epstein-Barr virus infection in young patients suggests a possible etiology for systemic lupus erythematosus. J. Clin. Invest. 100:3019.
2. James, J. A., B. R. Neas, K. L. Moser, T. Hall, G. R. Bruner, A. L. Sestak, and J. B. Harley. 2001. Systemic lupus erythematosus in adults is associated with previous Epstein-Barr virus exposure. Arthritis Rheum. 44:1122.
3. Incaprera, M., L. Rindi, A. Bazzichi, and C. Garzelli. 1998. Potential role of the Epstein-Barr virus in systemic lupus erythematosus autoimmunity. Clin. Exp. Rheumatol. 16:289.
4. Nagasawa, K., Y. Yamauchi, Y. Tada, T. Kusaba, Y. Niho, and H. Yoshikawa. 1990. High incidence of herpes zoster in patients with systemic lupus erythematosus: an immunological analysis. Ann. Rheum. Dis. 49:630.
5. Petri, M. 1998. Infection in systemic lupus erythematosus. Rheum. Dis. Clin. North Am. 24:423.
6. Kang, I., and S. H. Park. 2003. Infectious complications in SLE after immunosuppressive therapies. Curr. Opin. Rheumatol. 15:528.
7. Tsokos, G. C., P. L. Smith, C. B. Christian, R. N. Lipnick, J. E. Balow, and J. Y. Djeu. 1985. Interleukin-2 restores the depressed allogeneic cell-mediated lympholysis and natural killer cell activity in patients with systemic lupus erythematosus. Clin. Immunol. Immunopathol. 34:379.
8. Horwitz, D. A., W. Stohl, and J. D. Gray. 2001. T lymphocytes, natural killer cells, and immune regulation. In Dubois' Lupus Erythematosus. D. Wallace and B. Hahn, eds. Williams and Wilkins, Baltimore, p. 157.
9. Tsokos, G. C., I. T. Magrath, and J. E. Balow. 1983. Epstein-Barr virus induces normal B cell responses but defective suppressor T cell responses in patients with systemic lupus erythematosus. J. Immunol. 131:1797.
10. Papamichail, M., P. J. Sheldon, and E. J. Holborow. 1974. T- and B-cell subpopulations in infectious mononucleosis. Clin. Exp. Immunol. 18:1.
11. Schooley, R. T., B. F. Haynes, J. Grouse, C. Payling-Wright, A. S. Fauci, and R. Dolin. 1981. Development of suppressor T lymphocytes for Epstein-Barr virus-induced B-lymphocyte outgrowth during acute infectious mononucleosis: assessment by two quantitative systems. Blood 57:510.
12. + T cells during the primary immune response to Epstein-Barr virus in vivo. J. Exp. Med. 187:1395.
13. Hanto, D. W., G. Frizzera, K. J. Gajl-Peczalska, K. Sakamoto, D. T. Purtilo, H. H. Balfour, Jr., R. L. Simmons. and J. S. Najarian. 1982. Epstein-Barr virus-induced B-cell lymphoma after renal transplantation: acyclovir therapy and transition from polyclonal to monoclonal B-cell proliferation. N. Engl. J. Med. 306:913.
14. Cohen, J. I. 1991. Epstein-Barr virus lymphoproliferative disease associated with acquired immunodeficiency. Medicine 70:137.
15. Schoenberger, S. P., R. E. Toes, E. I. van der Voort, R. Offringa, and C. J. Melief. 1998. T-cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactions. Nature 393:480.
16. Bennett, S. R., F. R. Carbone, F. Karamalis, R. A. Flavell, J. F. Miller, and W. R. Heath. 1998. Help for cytotoxic-T-cell responses is mediated by CD40 signalling. Nature 393:478.
17. von Herrath, M. G., M. Yokoyama, J. Dockter, M. B. Oldstone, and J. L. Whitton. 1996. CD4-deficient mice have reduced levels of memory cytotoxic T lymphocytes after immunization and show diminished resistance to suhsequent virus challenge. J. Virol. 70:1072.
18. Shedlock, D. J., and H. Shen. 2003. Requirement for CD4 T cell help in generating functional CD8 T cell memory. Science 300:337.
19. Sun, J. C., and M. J. Bevan. 2003. Defective CD8 T cell memory following acute infection without CD4 T cell help. Science 300:339.
20. + T cells are detectable in most individuals with active HIV-1 infection, but decline with prolonged viral suppression. Nat. Med. 5:518.
21. Altfeld, M., E. S. Rosenberg, R. Shankarappa, J. S. Mukherjee, F. M. Hecht, R. L. Eldridge, M. M. Addo, S. H. Poon, M. N. Phillips, G. K. Robbins, et al. 2001. Cellular immune responses and viral diversity in individuals treated during acute and early HIV-1 infection. J. Exp. Med. 193:169.
22. Rooney, C. M., C. A. Smith, C. Y. Ng, S. K. Loftin, J. W. Sixbey, Y. Gan, D. K. Srivastava, L. C. Bowman, R. A. Krance, M. K. Brenner, et al. 1998. Infusion of cytotoxic T cells for the prevention and treatment of Epstein-Barr virus-induced lymphoma in allogeneic transplant recipients. Blood 92:1549.
23. + Epstein-Barr virus-specific cytotoxic T-lymphocytes from human umbilical cord blood. Cell. Immunol. 195:81.
24. + T cells and NK cells inhibit Epstein-Barr virus B-cell transformation in vitro. J. Virol. 76:5071.
25. + cytotoxic T cells from virus naive individuals. J. Immunol. 168:909.
26. Suni, M. A., L. J. Picker, and V. C. Maino. 1998. Detection of antigen-specific T cell cytokine expression in whole blood by flow cytometry. J. Immunol. Methods 212:89.
27. + T cell frequencies by flow cytometry: evidence for a novel, antigen-specific homeostatic mechanism in HIV-associated immunodeficiency. J. Clin. Invest. 99:1739.
28. Asanuma, H., M. Sharp, H. T. Maecker, V. C. Maino, and A. M. Arvin. 2000. Frequencies of memory T cells specific for varicella-zoster virus, herpes simplex virus, and cytomegalovirus by intracellular detection of cytokine expression. J. Infect. Dis. 181:859.
29. Bombardier, C., D. D. Gladman, M. B. Urowitz, D. Caron, and C. H. Chang. 1992. Derivation of the SLEDA1: a disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum. 35:630.
30. Picker, L. J., M. K. Singh, Z. Zdraveski, J. R. Treer, S. L. Waldrop, P. R. Bergstresser, and V. C. Maino. 1995. Direct demonstration of cytokine synthesis heterogeneity among human memory/effector T cells by flow cytometry. Blood 86:1408.
31. Marshall, N. A., J. G. Howe, R. Formica, D. Krause, J. E. Wagner, N. Berliner, J. Crouch, I. Pilip, D. Cooper, B. R. Blazar, et al. 2000. Rapid reconstitution of Epstein-Barr virus-specific T lymphocytes following allogeneic stem cell transplantation. Blood 96:2814.
32. + T cells specific for EBV in healthy virus carriers. J. Immunol. 162:1827.
33. + T cell memory: relationships between epitope specificity, cell phenotype, and immediate effector function. J. Immunol. 167:2019.
34. Strauch, B., L. L. Andrews, N. Siegel, and G. Miller. 1974. Oropharyngeal excretion of Epstein-Barr virus by renal transplant recipients and other patients treated with immunosuppressive drugs. Lancet 1:234.
35. Vratsanos, G., I. Kang, and J. Craft. 2001. Systemic lupus erythematosus. In Sainter's Immunologic Diseases, Vol. 2. K. F. Austen, M. M. Frank, J. P. Atkinson, and H. Cantor, eds. Lippincott Williams and Wilkins, Philadelphia, p. 475.
36. Niesters, H. G., J. van Esser, E. Fries, K. C. Wolthers, J. Cornelissen, and A. D. Osterhaus. 2000. Development of a real-time quantitative assay for detection of Epstein-Barr virus. J. Clin. Microbiol. 38:712.
37. Baldanti, F., P. Grossi, M. Furione, L. Simoncini, A. Sarasini, P. Comoli, R. Maccario, R. Fiocchi, and G. Gerna. 2000. High levels of Epstein-Barr virus DNA in blood of solid-organ transplant recipients and their value in predicting posttransplant lymphoproliferative disorders. J. Clin. Microbiol. 38:613.
38. Hanto, D. W., G. Frizzera, J. Gajl-Peczalska, D. T. Purtilo, G. Klein, R. L. Simmons, and J. S. Najarian. 1981. The Epstein-Barr virus (EBV) in the pathogenesis of posttransplant lymphoma. Transplant. Proc. 13:756.
39. Balandraud, N., J. B. Meynard, I. Auger, H. Sovran, B. Mugnier, D. Reviron, J. Roudier, and C. Roudier. 2003. Epstein-Barr virus load in the peripheral blood of patients with rheumatoid arthritis: accurate quantification using real-time polymerase chain reaction. Arthritis Rheum. 48:1223.
40. Smets, F., D. Latinne, H. Bazin, R. Reding, J. B. Otte, J. P. Buts, and E. M. Sokal. 2002. Ratio between Epstein-Barr viral load and anti-Epstein-Barr virus specific T-cell response as a predictive marker of posttransplant lymphoproliferative disease. Transplantation 73:1603.
41. + T lymphocytes and increased EBV load in HIV-1 infected individuals progressing to AIDS-related non-Hodgkin lymphoma. Blood 98:146.
42. Nived, O., A. Bengtsson, A. Jonsen, G. Sturfelt, and H. Olsson. 2001. Malignancies during follow-up in an epidemiologically defined systemic lupus erythematosus inception cohort in southern Sweden. Lupus 10:500.
43. Ramsey-Goldman, R., and A. E. Clarke. 2001. Double trouble: are lupus and malignancy associated? Lupus 10:388.
44. Wroblewski, J. M., A. Copple, L. P. Batson, C. D. Landers, and J. R. Yannelli. 2002. Cell surface phenotyping and cytokine production of Epstein-Barr virus (EBV)-transformed lymphoblastoid cell lines (LCLs). J. Immunol. Methods 264:19.
45. Moore, K. W., P. Vieira, D. F. Fiorentino, M. L. Trounstine, T. A. Khan, and T. R. Mosmann. 1990. Homology of cytokine synthesis inhibitory factor (IL-10) to the Epstein-Barr virus gene BCRF1. Science 248:1230.
46. + T-cell effectors inhibit Epstein-Barr virus-induced B-cell proliferation. J. Virol. 75:3740.
47. + T cells. Eur. J. Immunol. 32:1080.
48. Kovacsovics-Bankowski, M., K. Clark, B. Benacerraf, and K. L. Rock. 1993. Efficient major histocompatibility complex class I presentation of exogenous antigen upon phagocytosis by macrophages. Proc. Natl. Acad. Sci. USA 90:4942.
49. Carbone, F. R., and M. J. Bevan. 1990. Class I-restricted processing and presentation of exogenous cell-associated antigen in vivo. J. Exp. Med. 171:377.
50. + T cell response: lessons from the EBV nuclear antigen EBNA1. J. Immunol. 165:7078.
51. Buseyne, F., S. Le Gall, C. Boccaccio, J. P. Abastado, J. D. Lifson, L. O. Arthur, Y. Riviere, J. M. Heard, and O. Schwartz. 2001. MHC-I-restricted presentation of HIV-1 virion antigens without viral replication. Nat. Med. 7:344.
52. Vassilopoulos, D., B. Kovacs, and G. C. Tsokos. 1995. TCR/CD3 complex-mediated signal transduction pathway in T cells and T cell lines from patients with systemic lupus erythematosus. J. Immunol. 155:2269.
53. Yi, Y., M. McNerney, and S. K. Datta. 2000. Regulatory defects in Cb1 and mitogen-activated protein kinase (extracellular signal-related kinase) pathways cause persistent hyperexpression of CD40 ligand in human lupus T cells. J. Immunol. 165:6627.
54. + T cells from lupus-prone mice are hyperresponsive to t cell receptor engagement with low and high affinity peptide antigens: a model to explain spontaneous T cell activation in lupus. J. Exp. Med. 193:329.
55. + Th1 cells kill Burkitt's lymphoma cells. J. Immunol. 169:1593.
56. + T cells in systemic lupus erythematosus. J. Autoimmun. 17:155.
57. Stohl, W., J. E. Elliott, L. Li, E. R. Podack, D. H. Lynch, and C. O. Jacob. 1997. Impaired nonrestricted cytolytic activity in systemic lupus erythematosus: involvement of a pathway independent of Fas, tumor necrosis factor, and extracellular ATP that is associated with little detectable perforin. Arthritis Rheum. 40:1130.
58. Stohl, W., A. S. Hamilton, D. M. Deapen, T. M. Mack, and D. A. Horwitz. 1999. Impaired cytotoxic T lymphocyte activity in systemic lupus erythematosus following in vitro polyclonal T cell stimulation: a contributory role for non-T cells. Lupus 8:293.